Chief Sales Officer · SOPHiA GENETICS SA · Ordinary Shares
Side
SELL
Value
$145
Shares
30
Price
$4.83
Executed
Apr 6, 2026
Disclosed
Apr 8, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 6 executedApr 8, 2026 disclosed
SOPH · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+15 / 15
8 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Puylaert Kevin filed this Form 4 reporting a open-market sale of SOPH on Apr 6, 2026. It became public on Apr 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Sales Officer
Puylaert Kevincik:0002119354
Issuer
SOPHiA GENETICS SAcik:0001840706
Revision history · 0
No field has changed since this record was first ingested.
